The effect of flurbiprofen and benzydamine hydrochloride in sore throat due to the Laryngeal Mask Airway

Phase 4

Recruiting

• Conditions: Ear, Nose and Throat; Surgery; Anaesthesia

• Registration Number: PACTR201812490692464
• Lead Sponsor: Mogadishu Somalia Turkey Recep Tayyip Erdogan Training and Research Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1. The age of 18-60 years will be applied elective surgery
2. American Society of Anesthesia I-II
3. Mallampati I-II
4. They will be surgery in the supine position.
5. Lower limbs will be surgery
6. They will be intestinal surgery
7. They will be perianal surgery
8. They will have genital area surgery
9. 30 min - 1 hour surgical ones

Exclusion Criteria

1. Patients who do not agree to participate in the study
2. Upper airway anomaly or infection
3. Smokers with sore throat
4. Those who failed to enter the LMA installation
5. Pregnant, sick patients, those with drug allergy
6. Emergency surgery cases, Nasogastric catheter insertion
7. Patients who have used Flurbiprofen before
8. Those with a history of bronchospasm
9. Patients who cannot cooperate
10. Those with ASA III-IV, Mallampati III-IV

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
to evaluate the efficacy of flurbiprofen and benzidamine hydrochloride in preventing sore throat that may occur due to laryngeal mask airway application

Secondary Outcome Measures

Name	Time	Method
to evaluate other side effects (such as dryness of the throat, swallowing, nausea and vomiting) due to laryngeal mask airway application.